18F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1476-5578
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
18F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases ; day:17 ; month:8 ; year:2018 ; pages:1-12
Molecular psychiatry ; (17.8.2018), 1-12

Urheber
Grimmer, Timo
Beteiligte Personen und Organisationen
Shi, Kuangyu
Diehl-Schmid, Janine
Natale, Bianca
Drzezga, Alexander
Förster, Stefan
Förstl, Hans
Schwaiger, Markus
Yakushev, Igor
Wester, Hans-Jürgen
Kurz, Alexander
Yousefi, Behrooz Hooshyar
SpringerLink (Online service)

DOI
10.1038/s41380-018-0203-5
URN
urn:nbn:de:101:1-2018101420203843774217
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:21 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Grimmer, Timo
  • Shi, Kuangyu
  • Diehl-Schmid, Janine
  • Natale, Bianca
  • Drzezga, Alexander
  • Förster, Stefan
  • Förstl, Hans
  • Schwaiger, Markus
  • Yakushev, Igor
  • Wester, Hans-Jürgen
  • Kurz, Alexander
  • Yousefi, Behrooz Hooshyar
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Preclinical evaluation of [68Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo — a comparison to [68Ga]pentixafor

Preclinical evaluation of [68Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo — a comparison to [68Ga]pentixafor

Schwaiger, Markus

Akten

Schwaiger, Markus

[64Cu]NOTA-pentixather enables high resolution PET imaging of CXCR4 expression in a preclinical lymphoma model

[64Cu]NOTA-pentixather enables high resolution PET imaging of CXCR4 expression in a preclinical lymphoma model

The influence of different metal-chelate conjugates of pentixafor on the CXCR4 affinity

The influence of different metal-chelate conjugates of pentixafor on the CXCR4 affinity

Die grundherrlichen Abgaben des Sebastian Schredl, Kreuzmayr, und des Markus Schwaiger, Zeilmayr, beide zu Achtlfing gesessen

Amtsbücher, Register und Grundbücher

Die grundherrlichen Abgaben des Sebastian Schredl, Kreuzmayr, und des Markus Schwaiger, Zeilmayr, beide zu Achtlfing gesessen

PET / MR as tool for ”precision medicine”

PET / MR as tool for ”precision medicine”

Synthesis and in vitro and in vivo evaluation of urea-based PSMA inhibitors with increased lipophilicity

Synthesis and in vitro and in vivo evaluation of urea-based PSMA inhibitors with increased lipophilicity

Small peptide-based GLP-1R ligands: an approach to reduce the kidney uptake of radiolabeled GLP-1R-targeting agents?

Small peptide-based GLP-1R ligands: an approach to reduce the kidney uptake of radiolabeled GLP-1R-targeting agents?

Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies

Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies

PET imaging of chemokine receptor CXCR4 in patients with primary and recurrent breast carcinoma

PET imaging of chemokine receptor CXCR4 in patients with primary and recurrent breast carcinoma

Response assessment with the CXCR4-directed positron emission tomography tracer [68Ga]Pentixafor in a patient with extranodal marginal zone lymphoma of the orbital cavities

Response assessment with the CXCR4-directed positron emission tomography tracer [68Ga]Pentixafor in a patient with extranodal marginal zone lymphoma of the orbital cavities

Novel GRPR-targeted antagonists with improved pharmacokinetics for imaging and therapy of GRPR-expressing malignancies

Novel GRPR-targeted antagonists with improved pharmacokinetics for imaging and therapy of GRPR-expressing malignancies

Verbundene Objekte